Cronos Group Surges on U.S. Rescheduling Hopes: A Deep Dive into the Bull Case
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.